Madrigal Pharmaceuticals, Inc.
- Stock
- Ticker MDGL
- ISIN US5588681057
- Nasdaq
Performance, volatility and drawdowns of Madrigal Pharmaceuticals, Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $229,758. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −82.2% in 01/2022, measured from the peak in 06/2018. It took 77 months to get back to the old peak.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 103 | 137 | 213 | 287 | 321 | 311 | 364 | 431 |
| Gross profit | – | 133 | – | – | – | – | – | – |
| Operating income | -67 | -79 | -47 | -114 | -60 | -93 | -56 | 56 |
| EBITDA | -67 | -79 | -47 | -114 | -59 | -92 | -56 | 56 |
| Net income | -59 | -73 | -42 | -114 | -59 | -94 | -58 | 55 |
| Earnings per share | 2.00 | -2.61 | -1.50 | -4.01 | -2.03 | -3.25 | -1.99 | 1.83 |
| Balance sheet | ||||||||
| Total assets | 1,042 | 997 | 1,015 | 1,362 | 1,260 | 1,227 | 1,245 | 1,434 |
| Liabilities | 288 | 286 | 319 | 737 | 657 | 684 | 721 | 807 |
| Equity | 754 | 711 | 696 | 626 | 603 | 543 | 524 | 627 |
| Cash | 100 | 184 | 186 | 296 | 199 | 227 | 293 | 515 |
| Long-term debt | 118 | 118 | 118 | 340 | 340 | 340 | 341 | 341 |
| Cash flow | ||||||||
| Operating cash flow | -104 | -89 | -47 | 80 | -133 | -167 | 23 | 121 |
| Capital expenditure | -0.2 | 0.0 | 0.0 | -0.9 | 0.4 | -3.8 | -4.3 | -3.9 |
| Free cash flow | -105 | -89 | -47 | 79 | -133 | -171 | 19 | 117 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2017 at +516.0%, weakest 2021 at −23.8%. 6 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 3 Nov 2026 | $1.83 |
| 30 Jul 2026 | −$1.99 |
| 6 May 2026 | −$3.25 |
| 19 Feb 2026 | −$2.03 |
| 4 Nov 2025 | −$4.01 |
| 5 Aug 2025 | −$1.50 |
| 1 May 2025 | −$2.61 |
| 26 Feb 2025 | $2.00 |
| 31 Oct 2024 | −$4.92 |
| 7 Aug 2024 | −$7.10 |
| 7 May 2024 | −$7.38 |
| 28 Feb 2024 | −$5.68 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €8.0bn
- Market cap in trading currency
- $8.81bn
- Enterprise value
- $8.19bn
- P/E
- –
- P/S
- 6.17
- P/B
- 14.05
- EV/Sales
- 5.73
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- -1.9%
Results (last four quarters)
- Revenue
- $1.43bn
- Gross profit
- –
- EBITDA
- −$151m
- Net income
- −$155m
- Earnings per share
- −$5.44
- Revenue per share
- $61.47
- Revenue growth
- +50.1%
- Earnings growth
- –
Profitability
- Gross margin
- –
- Operating margin
- -10.7%
- Net margin
- -10.9%
- Return on equity
- -24.8%
- Return on assets
- -10.8%
Balance sheet and cash flow
- Cash
- $961m
- Cash per share
- $41.37
- Financial debt
- $341m
- Debt/equity %
- 54
- Current ratio
- 3.05
- Book value per share
- $26.99
- Operating cash flow
- −$157m
- Free cash flow
- −$169m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 23.2m
- Volume
- 327,823
- Avg. volume 3 months
- 356,696
- Relative volume
- 0.9
Price and technicals
- Price
- $379.10
- 1 day
- −4.4%
- 52-week high
- $602.83
- 52-week low
- $379.10
- Distance to 52-week high
- −37.1%
- Distance to 52-week low
- 0.0%
- Distance to 50-day line
- −18.0%
- Distance to 200-day line
- −23.3%
- RSI (14)
- 26
- Volatility 1M
- 50.7%
Performance
- 1 week
- −11.3%
- 1 month
- −16.4%
- 3 months
- −26.0%
- 6 months
- −26.7%
- YTD
- −34.9%
- 1 year
- −31.8%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has MDGL performed since 11/2016?
$10,000 grew to $229,758 by 20 Nov 2026, which is +36.8% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is MDGL?
Volatility was 134.1% per year, measured on monthly returns. The largest decline from a peak was −82.2%, with the low in 01/2022.
How does MDGL compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, MDGL returned +36.8% at 134.1%. The correlation of monthly returns was 0.03; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.